


Healthcare News Roundup: Oncology
HSMN NewsFeed - 22 Mar 2017
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia
HSMN NewsFeed - 21 Mar 2017
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
HSMN NewsFeed - 14 Mar 2017
Avelas Biosciences Appoints Alexey Vinogradov, Ph.D., to Board of Directors
Avelas Biosciences Appoints Alexey Vinogradov, Ph.D., to Board of Directors
HSMN NewsFeed - 13 Mar 2017
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
HSMN NewsFeed - 13 Mar 2017
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
HSMN NewsFeed - 8 Mar 2017
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
HSMN NewsFeed - 1 Mar 2017
Athenex Inc. announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer
Athenex Inc. announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer
HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
HSMN NewsFeed - 6 Feb 2017
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
HSMN NewsFeed - 30 Jan 2017
ZDi Solutions, LLC Announces Justin Sims as Executive Vice President of Sales
ZDi Solutions, LLC Announces Justin Sims as Executive Vice President of Sales
